Latest news

Mandatory notification of trade – employee share option scheme

Posted on Nov 30, 2015

Lysaker, 27 November 2015 – In accordance with the authorization granted by the Annual General Meeting 13th May 2014, the Board of Directors of PCI Biotech Holding ASA has awarded a total of 110,000 options to key employees. Each option gives the right to subscribe for or acquire one share per option (after PCI Biotech […]

PCI Biotech 3rd Quarter report

Posted on Nov 17, 2015

Lysaker, 17th November 2015 – Please find attached the third quarter 2015 report for PCI Biotech Holding ASA. Q3 2015 report Highlights include: Research collaboration with a top-10 large pharma company initiated The bile duct study has moved into the fourth dose cohort Research collaboration with RXi progressing according to plan Scientific Advisory Committee established […]

PCI Biotech to present at BIO-Europe

Posted on Nov 4, 2015

Press release, Lysaker, November 4th, 2015 – PCI Biotech will present at BIO-Europe on Wednesday, November 4th, 2015 at 10:00 a.m. local time at the International Congress Center in Munich, Germany. The presentation “Photochemical internalisation (PCI) – enhancing delivery in oncology” will be held in presentation room 2 (level 0) and the company will be […]